Aethlon Medical Inc (AEMD.OQ)
AEMD.OQ on NASDAQ Stock Exchange Capital Market
1.29USD
4:00pm EDT
1.29USD
4:00pm EDT
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$1.29
$1.29
Open
$1.28
$1.28
Day's High
$1.29
$1.29
Day's Low
$1.28
$1.28
Volume
3,710
3,710
Avg. Vol
74,951
74,951
52-wk High
$3.85
$3.85
52-wk Low
$0.80
$0.80
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec | 0.07 | -0.081 |
| Sep | 0.00 | -0.144 | |
| Jun | 0.00 | -0.209 | |
| FY 2017 | Mar '17 | 0.00 | -0.217 |
| Dec | 0.00 | -0.152 | |
| Sep | 0.39 | -0.291 | |
| Jun | 0.00 | -0.276 | |
| FY 2016 | Mar '16 | 0.20 | -0.164 |
| Dec | 0.30 | -0.160 | |
| Sep | 0.19 | -0.161 | |
| Jun | 0.19 | -0.176 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Mar-18 | 1 | 0.08 | 0.08 | 0.08 | -- |
| Year Ending Mar-19 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 1 | -0.08 | -0.08 | -0.08 | -- |
| Quarter Ending Dec-18 | 1 | -0.07 | -0.07 | -0.07 | -- |
| Year Ending Mar-18 | 1 | -0.48 | -0.48 | -0.48 | -- |
| Year Ending Mar-19 | 1 | -0.30 | -0.30 | -0.30 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 35.59 | 33.60 | |
| P/E High - Last 5 Yrs. | -- | 41.27 | 45.95 | |
| P/E Low - Last 5 Yrs. | -- | 21.23 | 24.93 | |
| Beta | 2.20 | 0.75 | 0.80 | |
| Price to Sales (TTM) | 287.98 | 7.57 | 7.07 | |
| Price to Book (MRQ) | 4.22 | 15.35 | 5.13 | |
| Price to Tangible Book (MRQ) | 4.66 | 25.14 | 6.73 | |
| Price to Cash Flow (TTM) | -- | 24.66 | 25.52 | |
| % Owned Institutions | 16.63 | 4.15 | 2.22 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.88 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 1.13 | 0.75 | |
| Dividend 5 Year Growth Rate | -- | 17.53 | 3.93 | |
| Payout Ratio(TTM) | -- | 27.53 | 20.35 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 14.74 | 9.02 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -87.46 | 11.05 | 10.83 | |
| Sales - 5 Yr. Growth Rate | -22.02 | 8.90 | 8.21 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 46.57 | 80.39 | 22.25 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 26.07 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 19.77 | 10.26 | |
| Capital Spending - 5 Yr. Growth Rate | 56.68 | 9.75 | 10.37 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.43 | 2.53 |
| Current Ratio (MRQ) | 16.72 | 3.21 | 3.62 |
| LT Debt to Equity (MRQ) | 17.26 | 29.05 | 11.31 |
| Total Debt to Equity (MRQ) | 17.26 | 33.43 | 13.97 |
| Interest Coverage (TTM) | -11.34 | 16.50 | 30.11 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 57.95 | 54.01 | |
| Gross Margin - 5 Yr. Avg. | -- | 57.51 | 52.12 | |
| EBITD Margin (TTM) | -6,724.86 | -- | -- | |
| EBITD - 5 Yr. Avg | -428.36 | 22.99 | 15.89 | |
| Operating Margin (TTM) | -7,273.41 | 19.12 | 4.33 | |
| Operating Margin - 5 Yr. Avg. | -533.14 | 15.65 | 11.25 | |
| Pre-Tax Margin (TTM) | -8,109.85 | 18.73 | 4.97 | |
| Pre-Tax Margin - 5 Yr. Avg. | -767.66 | 15.80 | 11.56 | |
| Net Profit Margin (TTM) | -8,109.85 | 14.51 | 1.58 | |
| Net Profit Margin - 5 Yr. Avg. | -767.66 | 10.93 | 7.89 | |
| Effective Tax Rate (TTM) | -- | 20.98 | 31.30 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 28.80 | 24.27 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 10,687 | 29,048,791 | 816,988,634 | |
| Net Income/Employee (TTM) | -866,711 | 3,716,463 | 96,050,323 | |
| Receivable Turnover (TTM) | -- | 4.90 | 5.56 | |
| Inventory Turnover (TTM) | -- | 3.00 | 3.45 | |
| Asset Turnover (TTM) | 0.02 | 0.75 | 0.89 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -185.52 | 10.67 | 10.54 | |
| Return on Assets - 5 Yr. Avg. | -508.88 | 8.90 | 11.56 | |
| Return on Investment (TTM) | -202.33 | 14.13 | 13.19 | |
| Return on Investment - 5 Yr. Avg. | -- | 11.62 | 14.97 | |
| Return on Equity (TTM) | -253.42 | 16.91 | 15.00 | |
| Return on Equity - 5 Yr. Avg. | -- | 14.09 | 16.25 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -55.78 | -37.73 | -22.02 |
| EPS (TTM) % | -42.21 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aethlon Medical Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Aethlon Medical Participates In Informational Meeting With FDA
- BRIEF-Aethlon Medical Announces Fiscal 2018 Third Quarter Results
- BRIEF-Aethlon Medical Says Granted U.S. Patent That Broadens Protection For The Aethlon Hemopurifier
- BRIEF-Sabrina Johnson Joins Aethlon Medical's Board Of Directors
- BRIEF-Aethlon Medical Names Dr. Charles J. Fisher Chairman Of The Board
Institutional Holders
| % Shares Owned: | 16.63% |
| # of Holders: | 19 |
| Total Shares Held: | 2,776,674 |
| 3 Mo. Net Change: | 100 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 1 |
| # Reduced Positions: | 0 |
| # Net Buyers: | 1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.